X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (392) 392
Newsletter (33) 33
Publication (24) 24
Book Review (23) 23
Book Chapter (10) 10
Newspaper Article (4) 4
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
denosumab (399) 399
osteoporosis (256) 256
index medicus (221) 221
humans (220) 220
postmenopausal women (156) 156
female (146) 146
fractures (123) 123
bone density conservation agents - therapeutic use (116) 116
zoledronic acid (110) 110
endocrinology & metabolism (102) 102
bisphosphonates (94) 94
drug therapy (93) 93
aged (92) 92
middle aged (87) 87
research (82) 82
osteoporosis, postmenopausal - drug therapy (77) 77
care and treatment (76) 76
alendronate (75) 75
male (75) 75
bone-mineral density (66) 66
denosumab - therapeutic use (64) 64
health aspects (64) 64
bones (62) 62
bone density - drug effects (61) 61
diphosphonates - therapeutic use (59) 59
orthopedics (59) 59
vertebral fractures (54) 54
rheumatology (53) 53
bone density (52) 52
risk factors (52) 52
therapy (52) 52
women (51) 51
bone density conservation agents - adverse effects (50) 50
bone mineral density (50) 50
endocrinology (50) 50
osteoporosis - drug therapy (50) 50
medicine & public health (48) 48
dosage and administration (46) 46
metastasis (46) 46
aged, 80 and over (45) 45
bone density conservation agents - administration & dosage (44) 44
prevention (43) 43
antibodies, monoclonal - therapeutic use (41) 41
antibodies, monoclonal, humanized (41) 41
patients (41) 41
discontinuation (40) 40
fracture (40) 40
antibodies, monoclonal, humanized - therapeutic use (38) 38
cancer (38) 38
density (38) 38
oncology (38) 38
pharmacology & pharmacy (37) 37
review (37) 37
analysis (35) 35
osteoporotic fractures - prevention & control (35) 35
complications and side effects (34) 34
immunotherapy (33) 33
prostate cancer (33) 33
vertebrae (33) 33
hormone replacement therapy (32) 32
rankl (32) 32
risk (32) 32
teriparatide (32) 32
bone turnover (31) 31
postmenopausal osteoporosis (31) 31
drug administration schedule (30) 30
breast cancer (29) 29
treatment outcome (29) 29
bisphosphonate (28) 28
bone remodeling - drug effects (28) 28
breast-cancer (28) 28
double-blind (28) 28
medical research (28) 28
bone metastases (27) 27
denosumab - administration & dosage (27) 27
denosumab - adverse effects (26) 26
medicine, general & internal (26) 26
osteonecrosis (26) 26
rank ligand - antagonists & inhibitors (26) 26
trial (26) 26
medicine, experimental (25) 25
monoclonal antibodies (25) 25
turnover (25) 25
abridged index medicus (24) 24
bone neoplasms - drug therapy (24) 24
treatment (24) 24
bone resorption (23) 23
hip (23) 23
patient outcomes (23) 23
persistence (23) 23
phosphonates (23) 23
antibodies, monoclonal - adverse effects (22) 22
bone density conservation agents - pharmacology (22) 22
cancer therapies (22) 22
cost-effectiveness (22) 22
diphosphonates - administration & dosage (22) 22
medicine, research & experimental (22) 22
post-menopause (22) 22
randomized controlled-trial (22) 22
rank ligand - therapeutic use (22) 22
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 02/2018, Volume 33, Issue 2, pp. 190 - 198
ABSTRACT Denosumab reduces bone resorption and vertebral and nonvertebral fracture risk. Denosumab discontinuation increases bone turnover markers 3 months... 
VERTEBRAL FRACTURES | BONE RESORPTION | DENOSUMAB | MULTIPLE VERTEBRAL FRACTURES | DISCONTINUATION | DENSITY | ENDOCRINOLOGY & METABOLISM | POSTMENOPAUSAL WOMEN | OSTEOPOROSIS | EXPOSURE | Clinical trials | Bones | Fractures | Density | Analysis | Bone resorption | Vertebrae | Bone mineral density | Bone turnover | Hip
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 06/2017, Volume 32, Issue 6, pp. 1291 - 1296
ABSTRACT We aimed to study the clinical and imaging characteristics of patients sustaining vertebral fractures after denosumab discontinuation. For this... 
FRACTURE | DENOSUMAB | DISCONTINUATION | OSTEOPOROSIS | VERTEBRAL | TRIAL | ENDOCRINOLOGY & METABOLISM | POSTMENOPAUSAL WOMEN | Spinal Fractures - drug therapy | Humans | Middle Aged | Aged, 80 and over | Aged | Withholding Treatment | Denosumab - therapeutic use | Fractures | Osteoporosis | Vertebrae | Spine (lumbar) | Aromatase | Thorax | Bone surgery | Post-menopause
Journal Article
Journal Article
Osteoporosis International, ISSN 0937-941X, 5/2016, Volume 27, Issue 5, pp. 1929 - 1930
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 03/2018, Volume 33, Issue 3, pp. 547 - 547
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 09/2015, Volume 30, Issue 9, pp. 1627 - 1640
ABSTRACT Osteonecrosis of the jaws (ONJ) is a significant complication of antiresorptive medications, such as bisphosphonates and denosumab. Antiresorptive... 
ZOLEDRONIC ACID | ALVEOLAR BONE | BISPHOSPHONATES | OSTEOCLASTS | DENOSUMAB | OSTEONECROSIS OF THE JAW (ONJ) | ANTIRESORPTIVES | alveolar bone | antiresorptives | zoledronic acid | osteoclasts | bisphosphonates | denosumab | osteonecrosis of the jaw (ONJ) | RISK-FACTORS | INDUCE OSTEONECROSIS | NITROGEN-CONTAINING BISPHOSPHONATES | BONE-RESORPTION | POSTMENOPAUSAL OSTEOPOROSIS | CANCER-PATIENTS | CLINICAL-APPLICATIONS | BISPHOSPHONATE-RELATED OSTEONECROSIS | ENDOCRINOLOGY & METABOLISM | EXPERIMENTAL PERIODONTITIS | KAPPA-B LIGAND | RANK Ligand - metabolism | Recombinant Fusion Proteins - pharmacology | Tartrate-Resistant Acid Phosphatase | Male | Mandible - diagnostic imaging | X-Ray Microtomography | Acid Phosphatase - metabolism | Isoenzymes - metabolism | Diphosphonates - therapeutic use | Disease Models, Animal | Bone Resorption | Maxilla - diagnostic imaging | Mice, Inbred C57BL | Osteoprotegerin - pharmacology | Abscess | Rats | Imidazoles - pharmacology | Osteoclasts - metabolism | Animals | RANK Ligand - antagonists & inhibitors | Bisphosphonate-Associated Osteonecrosis of the Jaw - pathology | Immunoglobulin Fc Fragments - pharmacology | Mice | Denosumab - pharmacology | Bisphosphonate-Associated Osteonecrosis of the Jaw - drug therapy | Diphosphonates - pharmacology | Osteoporosis | Bones | Phosphonates | Necrosis
Journal Article
Osteoporosis International, ISSN 0937-941X, 4/2017, Volume 28, Issue 4, pp. 1355 - 1363
Journal Article
Calcified Tissue International, ISSN 0171-967X, 7/2018, Volume 103, Issue 1, pp. 1 - 4
Journal Article
Joint Bone Spine, ISSN 1297-319X, 10/2018, Volume 85, Issue 5, pp. 515 - 517
Journal Article
Journal Article
Journal Article